ZINC00784494
ZINC00784494 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00784494 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00784494 has good potential for research in inflammatory breast cancer (IBC) [1].
Product Specifications
CAS Number
[317328-17-9]
UNSPSC
12352005
Target
Akt; Lipocalin Family
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zinc00784494.html
Purity
99.96
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C(C2=CSC(NC3=CC=CC(C(C)=O)=C3)=N2)=CC4=CC=CC=C4O1
Molecular Formula
C20H14N2O3S
Molecular Weight
362.40
References & Citations
[1]Santiago-Sánchez GS, et al. Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors. Int J Mol Sci. 2021 Aug 10;22 (16) :8581.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL316799V 500 µL Each
RND2 Human shRNA Lentiviral Particle (Locus ID 8153)
Sign In for Pricing
View Details 
MBS1251250-01 0.02 mg (E-Coli)
Recombinant Mycobacterium leprae Formamidopyrimidine-DNA glycosylase (mutM)
Sign In for Pricing
View Details MBS1251250-02 0.02 mg (Yeast)
Recombinant Mycobacterium leprae Formamidopyrimidine-DNA glycosylase (mutM)
Sign In for Pricing
View Details